abstract |
A pharmaceutical composition, comprising a thiazolidinedione, such as 5- [4- [2- (N-methyl-N- (2- pyridyl) amino) ethoxy] benzyl] -thiazolidine-2,4-dione (Compound (I) ), metformin hydrochloride and a pharmaceutically acceptable carrier, in which thiazolidinedione and metformin hydrochloride are each dispersed within their own pharmaceutically acceptable carrier in the pharmaceutical composition. |